Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Global regulation of the histone mark H3K36me2 underlies epithelial plasticity and metastatic progression.

Yuan S, Natesan R, Sanchez-Rivera FJ, Li J, Bhanu NV, Yamazoe T, Lin JH, Merrell AJ, Sela Y, Thomas SK, Jiang Y, Plesset JB, Miller EM, Shi J, Garcia BA, Lowe SW, Asangani IA, Stanger BZ.

Cancer Discov. 2020 Mar 18. pii: CD-19-1299. doi: 10.1158/2159-8290.CD-19-1299. [Epub ahead of print]

2.

Tumor Cell-Intrinsic USP22 Suppresses Antitumor Immunity in Pancreatic Cancer.

Li J, Yuan S, Norgard RJ, Yan F, Yamazoe T, Blanco A, Stanger BZ.

Cancer Immunol Res. 2020 Mar;8(3):282-291. doi: 10.1158/2326-6066.CIR-19-0661. Epub 2019 Dec 23.

PMID:
31871120
3.

Endoplasmic reticulum stress-induced cellular dysfunction and cell death in insulin-producing cells results in diabetes-like phenotypes in Drosophila.

Katsube H, Hinami Y, Yamazoe T, Inoue YH.

Biol Open. 2019 Dec 20;8(12). pii: bio046524. doi: 10.1242/bio.046524.

4.

Additional seizure reduction by replacement with Vagus Nerve Stimulation Model 106 (AspireSR).

Kawaji H, Yamamoto T, Fujimoto A, Uchida D, Ichikawa N, Yamazoe T, Okanishi T, Sato K, Nishimura M, Tanaka T, Namba H.

Neurosci Lett. 2020 Jan 18;716:134636. doi: 10.1016/j.neulet.2019.134636. Epub 2019 Nov 18.

PMID:
31751671
5.

iPreP is a three-dimensional nanofibrillar cellulose hydrogel platform for long-term ex vivo preservation of human islets.

Chen YJ, Yamazoe T, Leavens KF, Cardenas-Diaz FL, Georgescu A, Huh D, Gadue P, Stanger BZ.

JCI Insight. 2019 Nov 1;4(21). pii: 124644. doi: 10.1172/jci.insight.124644.

6.
7.

Tumor cell-intrinsic EPHA2 suppresses anti-tumor immunity by regulating PTGS2 (COX-2).

Markosyan N, Li J, Sun YH, Richman LP, Lin JH, Yan F, Quinones L, Sela Y, Yamazoe T, Gordon N, Tobias JW, Byrne KT, Rech AJ, FitzGerald GA, Stanger BZ, Vonderheide RH.

J Clin Invest. 2019 Jun 4;130:3594-3609. doi: 10.1172/JCI127755.

8.

Widespread interictal epileptic discharge more likely than focal discharges to unveil the seizure onset zone in EEG-fMRI.

Yamazoe T, von Ellenrieder N, Khoo HM, Huang YH, Zazubovits N, Dubeau F, Gotman J.

Clin Neurophysiol. 2019 Apr;130(4):429-438. doi: 10.1016/j.clinph.2018.12.014. Epub 2019 Jan 30.

PMID:
30769269
9.

Seizure frequency can be reduced by changing intracranial pressure: A case report in drug-resistant epilepsy.

Uchida D, Fujimoto A, Yamazoe T, Yamamoto T, Enoki H.

Epilepsy Behav Case Rep. 2018 Jan 10;10:14-17. doi: 10.1016/j.ebcr.2017.12.005. eCollection 2018.

10.

Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy.

Li J, Byrne KT, Yan F, Yamazoe T, Chen Z, Baslan T, Richman LP, Lin JH, Sun YH, Rech AJ, Balli D, Hay CA, Sela Y, Merrell AJ, Liudahl SM, Gordon N, Norgard RJ, Yuan S, Yu S, Chao T, Ye S, Eisinger-Mathason TSK, Faryabi RB, Tobias JW, Lowe SW, Coussens LM, Wherry EJ, Vonderheide RH, Stanger BZ.

Immunity. 2018 Jul 17;49(1):178-193.e7. doi: 10.1016/j.immuni.2018.06.006. Epub 2018 Jun 26.

11.

EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration.

Aiello NM, Maddipati R, Norgard RJ, Balli D, Li J, Yuan S, Yamazoe T, Black T, Sahmoud A, Furth EE, Bar-Sagi D, Stanger BZ.

Dev Cell. 2018 Jun 18;45(6):681-695.e4. doi: 10.1016/j.devcel.2018.05.027.

12.

[Experience and Solution of Complications of Vagus Nerve Stimulation Therapy in 139 Implant Patients with Medically Refractory Epilepsy].

Uchida D, Yamamoto T, Yamazoe T, Iijima K, Fujimoto A, Enoki H, Tanaka T.

No Shinkei Geka. 2017 Dec;45(12):1051-1057. doi: 10.11477/mf.1436203646. Japanese.

PMID:
29262385
13.

Successful corpus callosotomy for Doose syndrome.

Kanai S, Okanishi T, Nishimura M, Iijima K, Yokota T, Yamazoe T, Fujimoto A, Enoki H, Yamamoto T.

Brain Dev. 2017 Nov;39(10):882-885. doi: 10.1016/j.braindev.2017.06.001. Epub 2017 Jun 30.

PMID:
28673533
14.

New-onset refractory status epilepticus treated with vagus nerve stimulation: A case report.

Yamazoe T, Okanishi T, Yamamoto A, Yamada T, Nishimura M, Fujimoto A, Enoki H, Yokota T, Sato K, Yamamoto T.

Seizure. 2017 Apr;47:1-4. doi: 10.1016/j.seizure.2017.02.011. Epub 2017 Feb 24. No abstract available.

15.

Total corpus callosotomy for epileptic spasms after acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) in a case with tuberous sclerosis complex.

Okanishi T, Fujimoto A, Motoi H, Kanai S, Nishimura M, Yamazoe T, Takagi A, Yamamoto T, Enoki H.

Brain Dev. 2017 May;39(5):431-434. doi: 10.1016/j.braindev.2016.11.010. Epub 2016 Dec 4.

PMID:
27923529
16.

Wolf-Hirschhorn (4p-) syndrome with West syndrome.

Motoi H, Okanishi T, Kanai S, Yokota T, Yamazoe T, Nishimura M, Fujimoto A, Yamamoto T, Enoki H.

Epilepsy Behav Case Rep. 2016 Jul 15;6:39-41. doi: 10.1016/j.ebcr.2016.07.001. eCollection 2016.

17.

Hepatic Differentiation from Murine and Human iPS Cells Using Nanofiber Scaffolds.

Yamazoe T, Shiraki N, Kume S.

Methods Mol Biol. 2016;1357:475-83. doi: 10.1007/7651_2014_138.

PMID:
25410288
18.

Potent tumor tropism of induced pluripotent stem cells and induced pluripotent stem cell-derived neural stem cells in the mouse intracerebral glioma model.

Yamazoe T, Koizumi S, Yamasaki T, Amano S, Tokuyama T, Namba H.

Int J Oncol. 2015 Jan;46(1):147-52. doi: 10.3892/ijo.2014.2702. Epub 2014 Oct 8.

PMID:
25310640
19.

Generation of familial amyloidotic polyneuropathy-specific induced pluripotent stem cells.

Isono K, Jono H, Ohya Y, Shiraki N, Yamazoe T, Sugasaki A, Era T, Fusaki N, Tasaki M, Ueda M, Shinriki S, Inomata Y, Kume S, Ando Y.

Stem Cell Res. 2014 Mar;12(2):574-83. doi: 10.1016/j.scr.2014.01.004. Epub 2014 Jan 27.

20.

Diffuse astrocytoma initially presenting as a massive intracerebral hemorrhage: case report.

Nozaki T, Sato H, Yamazoe T, Namba H.

Neurol Med Chir (Tokyo). 2015;55(1):86-8. doi: 10.2176/nmc.cr.2013-0177. Epub 2014 Jan 10.

21.

[Effectiveness and role of lamotrigine in the paradigm shift towards new antiepileptic drugs: a therapeutic strategy proposed after an investigation of a large number of cases at a single hospital].

Yamamoto T, Yamazoe T, Fujimoto A, Kobayashi R, Yokota T, Okanishi T, Uchiyama G, Ohashi T, Tanaka T, Enoki H.

Brain Nerve. 2014 Jan;66(1):59-69. Japanese.

PMID:
24371132
22.

VMAT2 identified as a regulator of late-stage β-cell differentiation.

Sakano D, Shiraki N, Kikawa K, Yamazoe T, Kataoka M, Umeda K, Araki K, Mao D, Matsumoto S, Nakagata N, Andersson O, Stainier D, Endo F, Kume K, Uesugi M, Kume S.

Nat Chem Biol. 2014 Feb;10(2):141-8. doi: 10.1038/nchembio.1410. Epub 2013 Dec 15.

PMID:
24316738
23.

A synthetic nanofibrillar matrix promotes in vitro hepatic differentiation of embryonic stem cells and induced pluripotent stem cells.

Yamazoe T, Shiraki N, Toyoda M, Kiyokawa N, Okita H, Miyagawa Y, Akutsu H, Umezawa A, Sasaki Y, Kume K, Kume S.

J Cell Sci. 2013 Dec 1;126(Pt 23):5391-9. doi: 10.1242/jcs.129767. Epub 2013 Oct 7.

24.

Albumin gene targeting in human embryonic stem cells and induced pluripotent stem cells with helper-dependent adenoviral vector to monitor hepatic differentiation.

Umeda K, Suzuki K, Yamazoe T, Shiraki N, Higuchi Y, Tokieda K, Kume K, Mitani K, Kume S.

Stem Cell Res. 2013 Mar;10(2):179-94. doi: 10.1016/j.scr.2012.11.003. Epub 2012 Nov 27.

25.

[Clinical efficacy of the novel antiepileptic agent levetiracetam: evaluation in patients with localization-related epilepsy].

Yamazoe T, Fujimoto A, Yamazaki M, Yokota T, Okanishi T, Uchiyama T, Ohashi T, Tanaka T, Enoki H, Yamamoto T.

Brain Nerve. 2012 Oct;64(10):1169-74. Japanese.

PMID:
23037607
26.

Clinical utility of vagus nerve stimulation for progressive myoclonic epilepsy.

Fujimoto A, Yamazoe T, Yokota T, Enoki H, Sasaki Y, Nishimura M, Yamamoto T.

Seizure. 2012 Dec;21(10):810-2. doi: 10.1016/j.seizure.2012.08.009. Epub 2012 Sep 19. No abstract available.

27.

Comparison of dense array EEG with simultaneous intracranial EEG for interictal spike detection and localization.

Yamazaki M, Tucker DM, Fujimoto A, Yamazoe T, Okanishi T, Yokota T, Enoki H, Yamamoto T.

Epilepsy Res. 2012 Feb;98(2-3):166-73. doi: 10.1016/j.eplepsyres.2011.09.007. Epub 2011 Oct 20.

PMID:
22018998
28.

Efficient differentiation of embryonic stem cells into hepatic cells in vitro using a feeder-free basement membrane substratum.

Shiraki N, Yamazoe T, Qin Z, Ohgomori K, Mochitate K, Kume K, Kume S.

PLoS One. 2011;6(8):e24228. doi: 10.1371/journal.pone.0024228. Epub 2011 Aug 26.

29.

The AAA-ATPase NVL2 is a component of pre-ribosomal particles that interacts with the DExD/H-box RNA helicase DOB1.

Nagahama M, Yamazoe T, Hara Y, Tani K, Tsuji A, Tagaya M.

Biochem Biophys Res Commun. 2006 Aug 4;346(3):1075-82. Epub 2006 Jun 12.

PMID:
16782053
30.

NVL2 is a nucleolar AAA-ATPase that interacts with ribosomal protein L5 through its nucleolar localization sequence.

Nagahama M, Hara Y, Seki A, Yamazoe T, Kawate Y, Shinohara T, Hatsuzawa K, Tani K, Tagaya M.

Mol Biol Cell. 2004 Dec;15(12):5712-23. Epub 2004 Oct 6.

31.

Gene expression of bone matrix proteins in a calcified tissue appeared in subcutaneously transplanted rat dental pulp.

Yamazoe T, Aoki K, Simokawa H, Ohya K, Takagi Y.

J Med Dent Sci. 2002 Mar;49(1):57-66.

PMID:
12160227
32.

[Intravenous chronic toxicity of lentinan in rats: 6-month treatment and 3-month recovery (author's transl)].

Shimazu H, Takeda K, Onodera C, Makita I, Hashi T, Yamazoe T, Kokuba Y, Tanigawa H, Ohkuma S, Shinpo K, Takeuchi M.

J Toxicol Sci. 1980 Dec;5 Suppl:33-57. Japanese.

33.

Supplemental Content

Loading ...
Support Center